The vaccine targets tumour neoantigens to activate an anti-tumour immune response. It's a custom-built solution for each patient to prevent cancer recurrence.
[
add
]
[
|
|
...
]
The vaccine targets tumour neoantigens to activate an anti-tumour immune response. It's a custom-built solution for each patient to prevent cancer recurrence.